168 related articles for article (PubMed ID: 1734286)
21. [Regulation of crystalline lens aldose reductase activity. Nonhyperbolic oxidation kinetics of NADPH by glucose].
Vartanov SS; Pavlov AR; Iaropolov AI
Biokhimiia; 1990 Nov; 55(11):2046-57. PubMed ID: 2128191
[TBL] [Abstract][Full Text] [Related]
22. Convergent evolution of similar function in two structurally divergent enzymes.
Kuriyan J; Krishna TS; Wong L; Guenther B; Pahler A; Williams CH; Model P
Nature; 1991 Jul; 352(6331):172-4. PubMed ID: 2067578
[TBL] [Abstract][Full Text] [Related]
23. Structure of human aldose reductase holoenzyme in complex with statil: an approach to structure-based inhibitor design of the enzyme.
El-Kabbani O; Ramsland P; Darmanin C; Chung RP; Podjarny A
Proteins; 2003 Feb; 50(2):230-8. PubMed ID: 12486717
[TBL] [Abstract][Full Text] [Related]
24. An anion binding site in human aldose reductase: mechanistic implications for the binding of citrate, cacodylate, and glucose 6-phosphate.
Harrison DH; Bohren KM; Ringe D; Petsko GA; Gabbay KH
Biochemistry; 1994 Mar; 33(8):2011-20. PubMed ID: 8117658
[TBL] [Abstract][Full Text] [Related]
25. Structure of a glutathione conjugate bound to the active site of aldose reductase.
Singh R; White MA; Ramana KV; Petrash JM; Watowich SJ; Bhatnagar A; Srivastava SK
Proteins; 2006 Jul; 64(1):101-10. PubMed ID: 16639747
[TBL] [Abstract][Full Text] [Related]
26. Structural features of the aldose reductase and aldehyde reductase inhibitor-binding sites.
El-Kabbani O; Wilson DK; Petrash M; Quiocho FA
Mol Vis; 1998 Sep; 4():19. PubMed ID: 9756955
[TBL] [Abstract][Full Text] [Related]
27. The refined crystal structure of Bacillus cereus oligo-1,6-glucosidase at 2.0 A resolution: structural characterization of proline-substitution sites for protein thermostabilization.
Watanabe K; Hata Y; Kizaki H; Katsube Y; Suzuki Y
J Mol Biol; 1997 May; 269(1):142-53. PubMed ID: 9193006
[TBL] [Abstract][Full Text] [Related]
28. Polyol formation and NADPH-dependent reductases in dog retinal capillary pericytes and endothelial cells.
Sato S; Secchi EF; Lizak MJ; Fukase S; Ohta N; Murata M; Tsai JY; Kador PF
Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):697-704. PubMed ID: 10067973
[TBL] [Abstract][Full Text] [Related]
29. Structural studies on corn nitrate reductase: refined structure of the cytochrome b reductase fragment at 2.5 A, its ADP complex and an active-site mutant and modeling of the cytochrome b domain.
Lu G; Lindqvist Y; Schneider G; Dwivedi U; Campbell W
J Mol Biol; 1995 May; 248(5):931-48. PubMed ID: 7760334
[TBL] [Abstract][Full Text] [Related]
30. Crystal structure of NADP(H)-dependent 1,5-anhydro-D-fructose reductase from Sinorhizobium morelense at 2.2 A resolution: construction of a NADH-accepting mutant and its application in rare sugar synthesis.
Dambe TR; Kühn AM; Brossette T; Giffhorn F; Scheidig AJ
Biochemistry; 2006 Aug; 45(33):10030-42. PubMed ID: 16906761
[TBL] [Abstract][Full Text] [Related]
31. The crystal structure of d-glyceraldehyde-3-phosphate dehydrogenase from the hyperthermophilic archaeon Methanothermus fervidus in the presence of NADP(+) at 2.1 A resolution.
Charron C; Talfournier F; Isupov MN; Littlechild JA; Branlant G; Vitoux B; Aubry A
J Mol Biol; 2000 Mar; 297(2):481-500. PubMed ID: 10715215
[TBL] [Abstract][Full Text] [Related]
32. Structure of xylose reductase bound to NAD+ and the basis for single and dual co-substrate specificity in family 2 aldo-keto reductases.
Kavanagh KL; Klimacek M; Nidetzky B; Wilson DK
Biochem J; 2003 Jul; 373(Pt 2):319-26. PubMed ID: 12733986
[TBL] [Abstract][Full Text] [Related]
33. Crystal structure of Arabidopsis thaliana NADPH dependent thioredoxin reductase at 2.5 A resolution.
Dai S; Saarinen M; Ramaswamy S; Meyer Y; Jacquot JP; Eklund H
J Mol Biol; 1996 Dec; 264(5):1044-57. PubMed ID: 9000629
[TBL] [Abstract][Full Text] [Related]
34. Kinetic and spectroscopic evidence for active site inhibition of human aldose reductase.
Nakano T; Petrash JM
Biochemistry; 1996 Aug; 35(34):11196-202. PubMed ID: 8780524
[TBL] [Abstract][Full Text] [Related]
35. Structure-based optimization of aldose reductase inhibitors originating from virtual screening.
Eisenmann M; Steuber H; Zentgraf M; Altenkämper M; Ortmann R; Perruchon J; Klebe G; Schlitzer M
ChemMedChem; 2009 May; 4(5):809-19. PubMed ID: 19301313
[TBL] [Abstract][Full Text] [Related]
36. Aldose reductase catalysis and crystallography. Insights from recent advances in enzyme structure and function.
Petrash JM; Tarle I; Wilson DK; Quiocho FA
Diabetes; 1994 Aug; 43(8):955-9. PubMed ID: 8039602
[TBL] [Abstract][Full Text] [Related]
37. Anti-oxidant status in an in vitro model for hyperglycaemic lens cataract formation: competition for available nicotinamide adenine dinucleotide phosphate between glutathione reduction and the polyol pathway.
Hothersall JS; Muirhead RP; Taylaur CE; Jones RH
Biochem Int; 1992 Aug; 27(5):945-52. PubMed ID: 1417926
[TBL] [Abstract][Full Text] [Related]
38. The structure of Apo R268A human aldose reductase: hinges and latches that control the kinetic mechanism.
Bohren KM; Brownlee JM; Milne AC; Gabbay KH; Harrison DH
Biochim Biophys Acta; 2005 May; 1748(2):201-12. PubMed ID: 15769597
[TBL] [Abstract][Full Text] [Related]
39. Studies on pig aldose reductase. Identification of an essential arginine in the primary and tertiary structure of the enzyme.
Kubiseski TJ; Green NC; Borhani DW; Flynn TG
J Biol Chem; 1994 Jan; 269(3):2183-8. PubMed ID: 8294474
[TBL] [Abstract][Full Text] [Related]
40. Reduction of trioses by NADPH-dependent aldo-keto reductases. Aldose reductase, methylglyoxal, and diabetic complications.
Vander Jagt DL; Robinson B; Taylor KK; Hunsaker LA
J Biol Chem; 1992 Mar; 267(7):4364-9. PubMed ID: 1537826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
